• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床明显和隐匿性转移精原细胞瘤:在转录水平上几乎无法区分。

Clinically apparent and occult metastasized seminoma: almost indistinguishable on the transcriptional level.

作者信息

Ruf Christian G, Port Matthias, Schmelz Hans-Ulrich, Wagner Walter, Müller Felix, Senf Sven, Matthies Cord, Müller-Myhsok Bertram, Meineke Viktor, Abend Michael

机构信息

Department of Urology, Federal Armed Forces Hospital, Hamburg, Germany; Bundeswehr Institute of Radiobiology, Munich, Germany.

Bundeswehr Institute of Radiobiology, Munich, Germany; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, University Hospital Hannover, Hannover, Germany.

出版信息

PLoS One. 2014 May 1;9(5):e95009. doi: 10.1371/journal.pone.0095009. eCollection 2014.

DOI:10.1371/journal.pone.0095009
PMID:24788992
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4006798/
Abstract

PURPOSE

The aim of the present study was to examine the biological differences between seminomas with occult and clinically apparent metastases at the time of diagnosis of the primary tumor to gain insight into the biology of these tumors and facilitate the identification of novel predictors of seminoma metastasis.

MATERIALS AND METHODS

Total RNA including small RNAs was isolated from testicular tumors of patients with pure seminoma presenting with lymphogenic metastasis (n = 5, clinical stage IIb/c) and occult metastasis (n = 5, clinical stage I). The regulation of biological processes was examined (1) throughout the mRNA transcriptome (whole genome microarrays, 8×60 K Array, Agilent with 4 samples/group) and (2) the miRNA transcriptome employing small RNA next generation sequencing (SOLID, Life Technologies with 5 samples/group). Protein coding genes (mRNAs) and small RNAs showing a significant (≥2-fold) difference between the groups were identified. Finally (3), we examined 95 candidate miRNAs in 36 apparent metastasized and another 5 occult metastasized seminoma using logistic regression analysis.

RESULTS

Among 19,596 genes, on average 12,894 mRNAs appeared expressed (65.8%, SD+/-2.4; range, 62.0-69.3%) and 16.99×106/13.94×106 small RNA reads were identified for apparent/occult metastasized seminoma. These reads on average convert into 9,901/9,675 small RNAs including 422/404 mature microRNAs. None of these mRNAs/small RNAs met our selection criteria for candidate genes. From 95 candidate miRNAs 44 appeared expressed, with 3 of them showing weak but significant (p = 0.05) differences among both groups.

CONCLUSIONS

Occult and apparent metastasized seminomas are biologically almost indistinguishable and probably represent no separate tumor entities. These findings may simplify future research on seminoma metastasis.

摘要

目的

本研究旨在探讨原发性肿瘤诊断时伴有隐匿性转移和临床明显转移的精原细胞瘤之间的生物学差异,以深入了解这些肿瘤的生物学特性,并有助于识别精原细胞瘤转移的新预测指标。

材料与方法

从伴有淋巴转移(n = 5,临床分期IIb/c)和隐匿性转移(n = 5,临床分期I)的纯精原细胞瘤患者的睾丸肿瘤中分离包括小RNA在内的总RNA。检测生物学过程的调控情况:(1)通过mRNA转录组(全基因组微阵列,8×60 K芯片,安捷伦,每组4个样本);(2)采用小RNA下一代测序技术(SOLiD,生命技术公司,每组5个样本)检测miRNA转录组。鉴定出两组之间存在显著差异(≥2倍)的蛋白质编码基因(mRNA)和小RNA。最后(3),我们采用逻辑回归分析在36例临床明显转移和另外5例隐匿性转移的精原细胞瘤中检测了95个候选miRNA。

结果

在19,596个基因中,平均有12,894个mRNA表达(65.8%,标准差±2.4;范围,62.0 - 69.3%),在临床明显转移/隐匿性转移的精原细胞瘤中分别鉴定出16.99×10⁶/13.94×10⁶个小RNA读数。这些读数平均转化为9,901/9,675个小RNA,包括422/404个成熟微小RNA。这些mRNA/小RNA均未达到我们的候选基因选择标准。95个候选miRNA中有44个表达,其中3个在两组之间显示出微弱但显著(p = 0.05)的差异。

结论

隐匿性转移和临床明显转移精原细胞瘤在生物学上几乎无法区分,可能并不代表独立的肿瘤实体。这些发现可能会简化未来精原细胞瘤转移的研究。

相似文献

1
Clinically apparent and occult metastasized seminoma: almost indistinguishable on the transcriptional level.临床明显和隐匿性转移精原细胞瘤:在转录水平上几乎无法区分。
PLoS One. 2014 May 1;9(5):e95009. doi: 10.1371/journal.pone.0095009. eCollection 2014.
2
Small RNAs in the peripheral blood discriminate metastasized from non-metastasized seminoma.外周血中的小RNA可区分转移性与非转移性精原细胞瘤。
Mol Cancer. 2014 Mar 6;13:47. doi: 10.1186/1476-4598-13-47.
3
Predicting metastasized seminoma using gene expression.基于基因表达预测转移性精原细胞瘤。
BJU Int. 2012 Jul;110(2 Pt 2):E14-20. doi: 10.1111/j.1464-410X.2011.10778.x. Epub 2012 Jan 13.
4
Discriminating metastasised from non-metastasised seminoma based on transcriptional changes in primary tumours using NGS.基于 NGS 技术在原发性肿瘤中转录变化区分转移性和非转移性精原细胞瘤。
Br J Cancer. 2014 May 27;110(11):2738-46. doi: 10.1038/bjc.2014.134. Epub 2014 May 1.
5
A gene signature of primary tumor identifies metastasized seminoma.原发肿瘤基因特征可识别转移性精原细胞瘤。
Urol Oncol. 2011 Nov-Dec;29(6):764-73. doi: 10.1016/j.urolonc.2009.08.008. Epub 2009 Nov 27.
6
Immunohistochemistry expression of P53, Ki67, CD30, and CD117 and presence of clinical metastasis at diagnosis of testicular seminoma.睾丸精原细胞瘤诊断时P53、Ki67、CD30和CD117的免疫组化表达及临床转移情况
Appl Immunohistochem Mol Morphol. 2011 Mar;19(2):147-52. doi: 10.1097/PAI.0b013e3181f05a66.
7
Immunohistochemical expression of P53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage I disease.P53肿瘤抑制基因蛋白在成人睾丸生殖细胞肿瘤中的免疫组化表达:I期疾病的临床相关性
J Urol. 1994 Aug;152(2 Pt 1):418-23. doi: 10.1016/s0022-5347(17)32753-2.
8
Testicular seminoma metastasis to the gastrointestinal tract and the necessity of surgery.睾丸精原细胞瘤转移至胃肠道及手术的必要性。
J Gastrointest Cancer. 2012 Sep;43(3):499-501. doi: 10.1007/s12029-011-9274-0.
9
The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.精原细胞瘤的转移潜能与特定的 microRNA 模式相关。
Andrology. 2020 Nov;8(6):1687-1698. doi: 10.1111/andr.12838. Epub 2020 Aug 5.
10
Differences in global DNA methylation of testicular seminoma are not associated with changes in histone modifications, clinical prognosis, BRAF mutations or gene expression.睾丸精原细胞瘤中整体DNA甲基化的差异与组蛋白修饰、临床预后、BRAF突变或基因表达的变化无关。
Cancer Genet. 2016 Nov;209(11):506-514. doi: 10.1016/j.cancergen.2016.10.003. Epub 2016 Oct 31.

引用本文的文献

1
Seminoma metastasized to the prostate: A case report and literature review.精原细胞瘤转移至前列腺:一例报告及文献综述
Urol Case Rep. 2019 Dec 13;29:101096. doi: 10.1016/j.eucr.2019.101096. eCollection 2020 Mar.
2
Testicular orphan receptor 4 promotes tumor progression and implies poor survival through AKT3 regulation in seminoma.睾丸孤儿受体4通过调节精原细胞瘤中的AKT3促进肿瘤进展并提示预后不良。
Cancer Sci. 2018 Feb;109(2):384-394. doi: 10.1111/cas.13461.
3
Discriminating metastasised from non-metastasised seminoma based on transcriptional changes in primary tumours using NGS.基于 NGS 技术在原发性肿瘤中转录变化区分转移性和非转移性精原细胞瘤。
Br J Cancer. 2014 May 27;110(11):2738-46. doi: 10.1038/bjc.2014.134. Epub 2014 May 1.

本文引用的文献

1
MicroRNAs: cobblestones on the road to cancer metastasis.微小RNA:癌症转移之路上的铺路石
Crit Rev Oncog. 2013;18(4):341-55. doi: 10.1615/critrevoncog.2013007182.
2
A big catch for germ cell tumour research.生殖细胞肿瘤研究的重大发现。
PLoS Genet. 2013 Apr;9(4):e1003481. doi: 10.1371/journal.pgen.1003481. Epub 2013 Apr 11.
3
The search for biomarkers of metastatic seminoma.寻找转移性精原细胞瘤的生物标志物。
J Urol. 2013 Sep;190(3):1046-51. doi: 10.1016/j.juro.2013.04.022. Epub 2013 Apr 10.
4
Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing.睾丸生殖细胞癌的流行病学特征变化:诊断时的年龄和精原细胞瘤的相对频率持续显著增加。
Urol Oncol. 2014 Jan;32(1):33.e1-6. doi: 10.1016/j.urolonc.2012.12.002. Epub 2013 Feb 6.
5
MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.血清 microRNAs miR-371-3 作为睾丸生殖细胞肿瘤管理的诊断工具。
Br J Cancer. 2012 Nov 6;107(10):1754-60. doi: 10.1038/bjc.2012.469. Epub 2012 Oct 11.
6
Reliable and sample saving gene expression analysis approach for diagnostic tool development.用于诊断工具开发的可靠且节省样本的基因表达分析方法。
Health Phys. 2012 Aug;103(2):159-68. doi: 10.1097/HP.0b013e31824ac318.
7
Predicting metastasized seminoma using gene expression.基于基因表达预测转移性精原细胞瘤。
BJU Int. 2012 Jul;110(2 Pt 2):E14-20. doi: 10.1111/j.1464-410X.2011.10778.x. Epub 2012 Jan 13.
8
[EAU guidelines on testicular cancer: 2011 update. European Association of Urology].[欧洲泌尿外科学会睾丸癌指南:2011年更新版]
Actas Urol Esp. 2012 Mar;36(3):127-45. doi: 10.1016/j.acuro.2011.06.017. Epub 2011 Dec 20.
9
MicroRNAs as regulators of signal transduction in urological tumors.微小 RNA 作为泌尿肿瘤信号转导的调控因子。
Clin Chem. 2011 Jul;57(7):954-68. doi: 10.1373/clinchem.2010.157727. Epub 2011 Jun 1.
10
Identification of microRNAs From the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors.鉴定 miR-371~373 和 miR-302 簇中的 microRNAs 作为恶性生殖细胞肿瘤潜在的血清生物标志物。
Am J Clin Pathol. 2011 Jan;135(1):119-25. doi: 10.1309/AJCPOE11KEYZCJHT.